Inflammation Driven Activation of Wnt Pathway: A Potential Mechanism Responsible for Obesity-associated Colorectal Cancer
DOI:
https://doi.org/10.17140/OROJ-1-103Keywords:
Obesity; Inflammation; Wnt pathway; Colorectal cancerAbstract
Substantial evidence indicates that obesity, which has reached an epidemic proportion, is a robust risk factor for several types of cancer, particularly the colorectal cancer. As
the worldwide obesity epidemic has shown no sign to decrease, whereas further increases in
the scope of this problem are still projected, insight into the mechanisms of obesity-associated
tumorignesis is urgently needed for the development of preventive approaches to block this
process. Obesity is associated with multiple metabolic changes, and therefore a single mechanism is unlikely to be responsible for all obesity-associated tumors. A quite number of articles
provided systemic reviews of the possible mechanisms for the association between obesity and
the initiation and progression of cancers. In this mini-review, we focus on how obesity mediates
colorectal cancer via inflammation driven Wnt-signaling pathway
References
Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 104-117. doi: 10.3322/ caac.21220
World Health Organization. World Cancer Report 2014. Natu-ralezaCS; 2014.
Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epide-miology of obesity. Gastroenterology. 2007; 132: 2087-2102.
Calle EE, Kaaks R. Overweight, obesity and cancer: epide-miological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4: 579-591. doi: 10.1038/nrc1408
Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303: 235-241. doi: 10.1001/jama.2009.2014
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295: 1549-1555. doi: 10.1001/ jama.295.13.1549
Khandekar MJ, Cohen P, Spiegelman BM. Molecular mecha-nisms of cancer development in obesity. Nat Rev Cancer. 2011; 11: 886-895. doi: 10.1038/nrc3174
Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995; 6: 164-179.
Bardou M, Barkun AN, Martel M. Obesity and colorectal can-cer. Gut. 2013; 62: 933-947. doi: 10.1136/gutjnl-2013-304701
Irrazabal T, Belcheva A, Girardin SE, Martin A, Philpott DJ. The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell. 2014; 54: 309-320. doi: http://dx.doi.org/10.1016/j. molcel.2014.03.039
Aleman JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR. Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology. 2014; 146: 357-373. doi: 10.1053/j. gastro.2013.11.051
Silventoinen K, Sans S, Tolonen H, et al. Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord. 2004; 28: 710-718.
Wang Y, Monteiro C, Popkin BM. Trends of obesity and un-derweight in older children and adolescents in the United States, Brazil, China, and Russia. Am J Clin Nutr. 2002; 75: 971-977.
Rennie KL, Jebb SA. Prevalence of obesity in Great Britain. Obes Rev. 2005; 6: 11-12. doi: 10.1111/j.1467-789- X.2005.00164.x
Luo J, Hu FB. Time trends of obesity in pre-school children in China from 1989 to 1997. Int J Obes Relat Metab Disord. 2002; 26: 553-558.
Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002; 288: 1723-1727. doi: 10.1001/jama.2009.2014
Finkelstein EA, Khavjou OA, Thompson H, et al. Obesi-ty and severe obesity forecasts through 2030. Am J Prev Med. 2012; 42: 563-570. doi: 10.1016/j.amepre.2011.10.026
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospec-tively studied cohort of U.S. adults. N Engl J Med. 2003; 348: 1625-1638. doi: 10.1056/NEJMoa021423
Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alco-hol use, and diabetes with the risk of colorectal cancer. Cancer Res. 1997; 57: 4787-4794.
Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ. Body mass index and colon cancer mortality in a large prospec-tive study. Am J Epidemiol. 2000; 152: 847-854. doi: 10.1093/ aje/152.9.847
Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adoles-cents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992; 327: 1350-1355. doi: 10.1056/ NEJM199211053271904
Thun MJ, Calle EE, Namboodiri MM, et al. Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst. 1992; 84: 1491-1500. doi: 10.1093/jnci/84.19.1491
IARC. Weight control and physical activity. IARC hand-books of cancer prevention. Lyon, France: IARC Press; 2002.
Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obe-sity-linked insulin resistance. Science. 1993; 259: 87-91. doi: 10.1126/science.7678183
Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinol-ogy of adipose tissue - an update. Horm Metab Res. 2007; 39: 314-321. doi: 10.1055/s-2007-976539
Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006; 6: 772-783. doi: 10.1038/nri1937
Ramos EJ, Xu Y, Romanova I, et al. Is obesity an inflam-matory disease? Surgery. 2003; 134: 329-335. doi: http://dx.doi. org/10.1067/msy.2003.267
Ruan H, Zarnowski MJ, Cushman SW, Lodish HF. Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipo-cyte genes. J Biol Chem. 2003; 278: 47585-47593. doi: 10.1074/ jbc.M305257200
Howcroft TK, Campisi J, Louis GB, et al. The role of in-flammation in age-related disease. Aging (Albany NY). 2013; 5: 84-93.
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-867. doi: 10.1038/nature01322
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001; 48: 526- 535. doi: 10.1136/gut.48.4.526
Clapper ML, Cooper HS, Chang WC. Dextran sulfate so-dium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin. 2007; 28: 1450-1459. doi: 10.1111/j.1745-7254- .2007.00695.x
Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012; 188: 2127- 2135. doi: 10.4049/jimmunol.1102412
Spencer M, Finlin BS, Unal R, et al. Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with in-sulin resistance. Diabetes. 2013; 62: 1709-1717. doi: 10.2337/ db12-1042
Kim YS, Young MR, Bobe G, Colburn NH, Milner JA. Bioactive food components, inflammatory targets, and cancer prevention. Cancer Prev Res (Phila). 2009; 2: 200-208. doi: 10.1158/1940-6207.CAPR-08-0141
Grivennikov SI, Greten FR, Karin M. Immunity, inflam-mation, and cancer. Cell. 2013; 140: 883-899. doi: 10.1016/j. cell.2010.01.025
Taketo MM. Shutting down Wnt signal-activated cancer. Nat Genet. 2004; 36: 320-322. doi: 10.1038/ng0404-320
Network CGA. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012; 487: 330-337. doi: 10.1038/nature11252
Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996; 87: 159-170. doi: http://dx.doi.org/10.1016/ S0092-8674(00)81333-1
Bienz M, Clevers H. Linking colorectal cancer to Wnt sig-naling. Cell. 2000; 103: 311-320. doi: http://dx.doi.org/10.1016/ S0092-8674(00)00122-7
White BD, Chien AJ, Dawson DW. Dysregulation of Wnt/ beta-catenin signaling in gastrointestinal cancers. Gastroenterol-ogy. 2012; 142: 219-332. doi: 10.1053/j.gastro.2011.12.001
Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactiva-tion of SFRP genes allows constitutive Wnt signaling in colorec-tal cancer. Nat Genet. 2004; 36: 417-422. doi: 10.1038/ng1330
Aguilera O, Fraga MF, Ballestar E, et al. Epigenetic inacti-vation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 2006; 25: 4116-4121. doi: 10.1038/sj.onc.1209439
Ying Y, Tao Q. Epigenetic disruption of the Wnt/beta-catenin signaling pathway in human cancers. Epigenetics. 2009; 4: 307- 312.
Wu D, Pan W. GSK3: a multifaceted kinase in Wnt sig-naling. Trends Biochem Sci. 35: 161-168. doi: 10.1016/j. tibs.2009.10.002
Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol. 2006; 7: 885-896. doi: 10.1038/nrm2066
Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A. Adi-pogenesis and Wnt signalling. Trends Endocrinol Metab. 2009; 20: 16-24. doi: 10.1016/j.tem.2008.09.002
Ross SE, Hemati N, Longo KA, et al. Inhibition of adipo-genesis by Wnt signaling. Science. 2000; 289: 950-953. doi: 10.1126/science.289.5481.950
Ouchi N, Higuchi A, Ohashi K, et al. Sfrp5 is an anti-inflam-matory adipokine that modulates metabolic dysfunction in obesi-ty. Science. 2010; 329: 454-457. doi: 10.1126/science.1188280
Gustafson B, Smith U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid ac-cumulation in 3T3-L1 preadipocytes. J Biol Chem. 2006; 281: 9507-9516. doi: 10.1074/jbc.M512077200
Cawthorn WP, Heyd F, Hegyi K, Sethi JK. Tumour ne-crosis factor-alpha inhibits adipogenesis via a beta-catenin/ TCF4(TCF7L2)-dependent pathway. Cell Death Differ. 2007; 14: 1361-1373. doi: 10.1038/sj.cdd.4402127
Oguma K, Oshima H, Aoki M, et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J. 2008; 27: 1671-1681. doi: 10.1038/emboj.2008.105
Liu Z, Brooks RS, Ciappio ED, et al. Diet-induced obesity elevates colonic TNF-alpha in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer. J Nutr Biochem. 2012; 23: 1207-1213. doi: 10.1016/j.jnutbio.2011.07.002
Kaler P, Augenlicht L, Klampfer L. Macrophage-derived IL-1beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3. Oncogene. 2009; 28: 3892-3902. doi: 10.1038/onc.2009.247
Nava P, Koch S, Laukoetter MG, et al. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity. 2010; 32: 392-402. doi: 10.1016/j.immuni.2010.03.001
Lumeng CN, Saltiel AR. Inflammatory links between obe-sity and metabolic disease. J Clin Invest. 2011; 121: 2111-2117. doi: 10.1172/JCI57132
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Obesity Research (OR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
